Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DMT
Recent news which mentions DMT
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
February 21, 2024
Tickers
CMND
CMND
DMT
NEWS
Tags
CMND
Psychedelics
United States Patent and Trademark Office
From
Benzinga
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
January 02, 2024
Tickers
DEA
DMT
MDMA
NEWS
Tags
Cannabis Research
Government
Delta/9 THC
From
Benzinga
More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health
December 13, 2023
Tickers
DMT
MDMA
Tags
DMT
Markets
LSD
From
Benzinga
Psychedelics In Mexico: Are They Legal? Well, Yes And No
December 10, 2023
Tickers
DMT
Tags
Market News
Cannabis
contributors
From
Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
October 20, 2023
Tickers
CYBN
DMT
DMTTF
Tags
Psychedelics
Market News
Cannabis
From
Benzinga
The Fear Of Death Dissolved: How Psychedelic Trips And Near-Death Moments Change Our Outlook On Life's End
August 17, 2023
Tickers
DMT
Tags
LSD
Markets
DMT
From
Benzinga
How DMT Affects The Brain's Advanced Functions, Scientists Reveal The Truth
April 29, 2023
Tickers
DMT
Tags
Study
General
Psychedelics
From
Benzinga
Study Sheds Light On How A Brain On Ayahuasca's Psychedelic Component Looks
March 24, 2023
Tickers
DMT
Tags
Benzinga
Psychedelic/Assisted Therapies
Global
From
Benzinga
DMT VS. Psilocybin: Are We All Experiencing The Same Trip?
February 10, 2023
Tickers
DMT
Tags
contributors
Benzinga
DMT
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
Markets
first/in/human dosing
DMT
From
Benzinga
Top 3 Psychedelic Storylines To Watch In 2023
January 29, 2023
Tickers
ATAI
CMPS
DMT
MDMA
Tags
contributors
Penny Stocks
Benzinga
From
Benzinga
EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
January 26, 2023
Tickers
DMT
FLHLF
Tags
Small Cap
Psychedelics
Market News
From
Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
January 18, 2023
Tickers
AGNPF
DMT
Tags
News
AGNPF
Human Stroke
From
Benzinga
Ayahuasca's Benefits Outweigh Risks, A New Australian Study Finds
November 28, 2022
Tickers
DMT
Tags
Plos Global Public Health
News
Ayahuasca
From
Benzinga
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
October 31, 2022
Tickers
DMT
DMTTF
Tags
Short/Acting Psychedelics
News
Legal
From
Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
September 12, 2022
Tickers
AGNPF
DMT
Tags
Cannabis
The Netherlands
Market News
From
Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
August 29, 2022
Tickers
DMT
PSYBF
TRUFF
Tags
Penny Stocks
Global
Benzinga
From
Benzinga
Science Feature: Next-Generation Psychedelics
July 31, 2022
Tickers
DMT
Tags
Ibogaine
Psilocybin
Psychedelics
From
Benzinga
Encountering DMT Entities: Are They Real?
June 23, 2022
Tickers
DMT
Tags
contributors
Benzinga
DMT
From
Benzinga
A Deeper Look At DMT Trials & Studies
June 14, 2022
Tickers
DMT
Tags
Psychedelics
Cannabis
Markets
From
Benzinga
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
April 19, 2022
Tickers
CYBN
DMT
PCC
Tags
CYBN
News
PCC22
From
Benzinga
Extending the Experience: Interview With DMT Pioneer Rick Strassman
April 16, 2022
Tickers
DMT
Tags
Psychedelics
Rick Strassman
Benzinga
From
Benzinga
Top 5 Most Influential Psychedelic Studies
March 29, 2022
Tickers
DMT
MDMA
Tags
Psychedelics Research
DMT
Markets
From
Benzinga
Forget Shrooms, Is Toad Venom The New Hallucinogenic Drug For The Rich And Famous?
March 06, 2022
Tickers
DMT
Tags
toad venom
psychedelics
Bufo
From
Benzinga
DMT Vape Pen Patent Illustrates A Big Problem In The Psychedelics Industry
February 14, 2022
Tickers
DMT
Tags
DMT Vape Pen
psychedelics
Benzinga
From
Benzinga
Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
February 12, 2022
Tickers
DMT
Tags
DMT
Market News
Markets
From
Benzinga
Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca's Active Ingredient
February 03, 2022
Tickers
DMT
ENTBF
Tags
Dr/ Andrew Hegle
Benzinga
Penny Stocks
From
Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
January 19, 2022
Tickers
DMT
MDMA
Tags
Compass Pathways
Defiance Altered Experience ETF (PSY)
psilocybin
From
Stock Gumshoe
A Deeper Look At DMT, The 'Spirit Molecule'
January 12, 2022
Tickers
DMT
Tags
psychedelics
Ayahuasca
5/MeO/DMT
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.